Recalcitrant MAC Lung Disease, Resistant MAC, and M abscessus Infections
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Recalcitrant MAC Lung Disease, Resistant MAC, and M abscessus Infections
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
In this episode, host Doreen Addrizzo-Harris, MD, FCCP, is joined by Amy Springer, MSN, FNP-C, to explore the challenges and treatment strategies for recalcitrant Mycobacterium avium complex (MAC) pulmonary disease, resistant MAC, and Mycobacterium abscessus (M abscessus) infections. They discuss diagnostic considerations, antibiotic resistance, treatment regimens—including US Food and Drug Administration-approved therapies and surgical options—and the critical role of patient compliance.
This episode is part of CHEST’s Bridging Specialties®: Timely Diagnosis for NTM Disease and Bronchiectasis program. LEARN MORE »
This program is produced in partnership with CHEST and is sponsored by Insmed Incorporated.
Originally aired: July 1, 2025
HOST
Doreen J. Addrizzo-Harris, MD, FCCP
Fiona and Stanley Druckenmiller Professor of Pulmonary, Critical Care, and Sleep Medicine
Director, NYULH Bronchiectasis and NTM Clinical and Translational Program
NYU Grossman School of Medicine
New York, NY
PANELIST
Amy Springer, MSN, FNP-C
Senior Nurse Practitioner, NYULH Bronchiectasis and NTM Clinical and Translational Program
Division of Pulmonary, Critical Care, and Sleep Medicine
NYU Langone Health
New York, NY